| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hersey Christine Ann | Chief Corp Affairs & Strategy | C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY | /s/ Eric Powers, as Attorney-in-Fact | 27 Jan 2026 | 0002107378 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TCNNF | Subordinate Voting Shares | 85,173 | 14 Jan 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 2,925 | $47.23 | Direct | F2, F3 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 1,097 | $27.17 | Direct | F2, F4 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 4,387 | $18.45 | Direct | F2, F5 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 7,955 | $21.48 | Direct | F6 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 53,754 | $3.99 | Direct | F7 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 28,519 | $10.00 | Direct | F8 | ||||||
| holding | TCNNF | Stock Option (Right to Buy) | 14 Jan 2026 | Subordinate Voting Shares | 72,340 | $4.03 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The reporting person: (i) was granted 8,380 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2023 and December 1, 2024; (ii) was granted 24,156 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2024 and December 1, 2025; (iii) was granted 15,750 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs vested 50% on December 1, 2025 and will vest 50% on December 1, 2026; and (iv) was granted 43,424 RSUs on March 25, 2025, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2026 and 50% on December 1, 2027. |
| F2 | These options were originally granted under the Harvest Health & Recreation Inc. 2018 Stock and Incentive Plan and, in connection with Trulieve's acquisition of Harvest Health & Recreation Inc. on October 1, 2021, were converted into options to purchase Trulieve subordinate voting shares at an adjusted exercise price. |
| F3 | The options were granted on September 10, 2019, and vest 25% per year in equal installments, starting on the grant date. One fourth of the options vested and became exercisable on each of September 10, 2019, September 10, 2020, September 10, 2021 and September 10, 2022. |
| F4 | The options were granted February 3, 2020, and vest 25% per year in equal installments, starting on September 10, 2019. One fourth of the options vested and became exercisable on each of September 10, 2019, September 10, 2020, September 10, 2021 and September 10, 2022. |
| F5 | The options were granted on December 31, 2020, and vest 50% per year in equal installments, starting on the grant date. One half of the options vested and became exercisable on each of December 31, 2020 and December 31, 2021. |
| F6 | The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022, December 1, 2023 and December 1, 2024. |
| F7 | The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2023, December 1, 2024 and December 1, 2025. |
| F8 | The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2024 and December 1, 2025, and one third of the options will vest and become exercisable on December 1, 2026. |
| F9 | The options were granted on March 25, 2025, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2025, one third of the options will vest and become exercisable on December 1, 2026, and one third of the options will vest and become exercisable on December 1, 2027. |
Exhibit 24 Power of Attorney filed herewith.